Departments

Humer Novin Daroo

Quality Control (QC):

The Quality Control department is responsible for the comprehensive testing and analysis of biopharmaceutical products to ensure they meet specified quality and compliance standards. Utilizing advanced analytical techniques and state-of-the-art instrumentation, our QC specialists perform a variety of tests, including protein characterization, potency assays, purity testing, etc. GMP is essential in QC to verify product integrity and consistency, ensuring that every batch of our biopharmaceutical products is reliable and of the highest quality. By adhering to GMP guidelines, we maintain our products' reputation and reliability in the market, reinforcing our commitment to excellence and patient safety.


Quality Assurance (QA) :

The Quality Assurance department at Humer Daroo is dedicated to implementing and maintaining robust quality systems that ensure the safety, efficacy, and compliance of our biopharmaceutical products. Our QA professionals establish and enforce stringent quality standards and procedures across the entire manufacturing process, from raw material sourcing to the release of finished products. GMP plays a vital role in QA, as it involves conducting rigorous audits, inspections, and quality oversight activities. By upholding these high standards, we ensure that all products meet regulatory compliance and maintain the highest levels of quality, safeguarding patient health and maintaining trust in our products.


Regulatory Affairs:

Regulatory Affairs plays a pivotal role in ensuring compliance with Iranian regulatory requirements governing the development, manufacturing, and marketing of biopharmaceutical products. Our dedicated team navigates the intricate landscape of Iranian regulations, liaising closely with regulatory authorities to secure approvals and maintain product compliance throughout the product lifecycle. By staying abreast of evolving regulatory requirements in Iran, we ensure timely approvals and market access for our biopharmaceutical products, while upholding the highest standards of regulatory compliance and patient safety.


Sales & Marketing:

The Sales & Marketing department develops strategic initiatives to promote our biopharmaceutical products and drive market adoption. Leveraging our deep understanding of the therapeutic landscape and customer needs, our team of marketing professionals designs targeted campaigns and educational programs to raise awareness and facilitate adoption by healthcare providers and patients. Through collaboration with key opinion leaders and strategic partners, we aim to maximize the reach and impact of our biopharmaceutical portfolio in the market.


Fill and Finish:

The Fill and Finish department is a critical part of our manufacturing process, responsible for the final preparation of biopharmaceutical products before they are distributed for use. This involves filling sterile containers and cartridges with biopharmaceutical products, sealing and inspecting them for quality assurance, and labeling them with essential information such as product name, dosage, batch number, and expiration date. This department ensures that all products are filled accurately and safely under stringent aseptic conditions to prevent contamination. The Fill and Finish team also manages primary and secondary packaging, ensuring the products are protected and ready for distribution. Quality control measures are integral to this department to ensure all filled and finished products meet regulatory standards and maintain the highest levels of safety and efficacy.


Manufacturing:

Our Manufacturing department is crucial for producing high-quality biopharmaceutical products using recombinant DNA technology. We operate state-of-the-art bioprocessing facilities, where bioprocess engineers and production specialists use advanced techniques such as cell culture, fermentation, purification, and formulating to create recombinant proteins and antibodies. Good Manufacturing Practices (GMP) are fundamental in this department to ensure quality, efficiency, and scalability. By adhering to GMP standards, we guarantee that our production processes are consistently controlled and documented, resulting in safe and effective biopharmaceutical products that meet patient needs on time and in compliance with regulatory requirements.


Science:

The Science department at Humer Daroo encompasses a broad range of functions, including pharmacovigilance, clinical trials, and scientific advisory services. Our pharmacovigilance team ensures the ongoing safety and efficacy of our biopharmaceutical products through rigorous monitoring and reporting of adverse events. The clinical trials team meticulously designs and conducts clinical studies in adherence to Good Clinical Practice (GCP) guidelines to evaluate the safety and effectiveness of our therapies. Our scientific advisory services provide critical insights and guidance to inform research, development, and regulatory strategies, ensuring that our products meet the highest standards of scientific and clinical excellence. By integrating these functions, the Science department plays a pivotal role in advancing medical science and ensuring patient safety.


Research & Development:

At Humer Daroo, our Research & Development department is dedicated to pioneering advancements in biopharmaceuticals while harnessing the power of cutting-edge recombinant DNA technology. Our experienced team of scientists and researchers collaboratively leverages innovative techniques to engineer therapeutic solutions, including therapeutic proteins, monoclonal antibodies, and peptides. Through rigorous testing and regulatory approval, we are committed to addressing unmet medical needs and improving patient outcomes. Our focus on excellence, innovation, and patient-centric care drives our mission to bring impactful treatments to patients in need and advance the frontiers of biotechnology.


Human Resources:

The Human Resources department is dedicated to attracting, developing, and retaining top talent to support our biopharmaceutical innovation and growth. Our team of HR professionals designs and implements talent acquisition strategies, employee development programs, and performance management systems to nurture a culture of excellence and collaboration. By investing in our people and fostering a diverse and inclusive workplace, we cultivate a talented workforce capable of driving our mission forward.


Finance:

The Finance department oversees financial planning, budgeting, and analysis to support the strategic objectives of Humer Daroo's biopharmaceutical business. Our team of finance professionals collaborates with departmental leaders to allocate resources effectively, monitor financial performance, and identify opportunities for cost optimization and revenue growth. By maintaining financial transparency and accountability, we support the long-term sustainability and success of our biopharmaceutical operations.


Information Technology:

The Information Technology department provides strategic direction and operational support for the IT infrastructure and systems that underpin Humer Daroo's biopharmaceutical activities. Our team of IT professionals ensures the reliability, security, and scalability of IT systems, enabling seamless collaboration and data-driven decision-making across the organization. From implementing advanced technologies to providing technical support and training, we empower our teams to innovate and excel in a rapidly evolving digital landscape.


Legal:

The Legal department provides expert legal counsel and support to ensure compliance with laws and regulations governing the biopharmaceutical industry. Our team of legal experts advises on regulatory compliance, intellectual property protection, and commercial agreements, safeguarding the company's interests and mitigating legal risks. By upholding the highest standards of legal and ethical conduct, we support Humer Daroo's mission to deliver innovative biopharmaceutical solutions to patients in need.


Strategy & Business Development:

The Strategy & Business Development department is responsible for identifying growth opportunities and driving strategic initiatives to expand Humer Daroo's presence in the biopharmaceutical market. Our team of strategic planners and business development professionals conducts market analysis, evaluates partnership opportunities, and develops strategic plans to capitalize on emerging trends and market dynamics. By aligning business objectives with market opportunities, we drive sustainable growth and create long-term value for the organization and its stakeholders.


Commerce & Trade:

The Commerce & Trade department at Humer Daroo manages import and export activities, oversees international trade agreements, and develops market entry strategies to facilitate the global exchange of our biopharmaceutical products. With a focus on navigating the complexities of international trade regulations and customs procedures, our team ensures compliance with Iranian trade laws and regulations while fostering international partnerships and collaborations. By leveraging our expertise in trade negotiations and logistics management, we optimize supply chain operations and enhance market access for our biopharmaceutical portfolio, contributing to the company's global growth and competitiveness.